TABLE A2.
Univariable Associations With RFS and OS
| Variable | RFS |
OS |
|||
|---|---|---|---|---|---|
| N | HR (95% CI) | P | HR (95% CI) | P | |
|
| |||||
| Sex | 202 | ||||
|
| |||||
| Female | - | - | |||
|
| |||||
| Male | 1.08 (0.69 to 1.68) | .7 | 1 (0.60 to 1.67) | >.9 | |
|
| |||||
| Age at surgery | 202 | 1.01 (0.99 to 1.03) | .4 | 1.02 (0.99 to 1.05) | .14 |
|
| |||||
| Primary v secondary | 202 | ||||
|
| |||||
| Primary | - | - | |||
|
| |||||
| Secondary | 1.45 (0.93 to 2.26) | .1 | 1.33 (0.79 to 2.23) | .3 | |
|
| |||||
| Variant histology | 202 | 1.19 (0.80 to 1.75) | .4 | 1.1 (0.71 to 1.72) | .7 |
|
| |||||
| Pathologic stage groups | 202 | ||||
|
| |||||
| ≤pT2 | - | - | |||
|
| |||||
| pT3 | 2.52 (1.52 to 4.19) | <.001 | 2.31 (1.31 to 4.07) | .004 | |
|
| |||||
| pT4 | 4.33 (2.36 to 7.94) | <.001 | 2.91 (1.42 to 5.98) | .004 | |
|
| |||||
| Concurrent carcinoma in situ | 201 | 1.31 (0.87 to 1.97) | .2 | 1.51 (0.94 to 2.43) | .092 |
|
| |||||
| Lymphovascular invasion | 202 | 3.1 (2.06 to 4.67) | <.001 | 3.12 (1.94 to 5.03) | <.001 |
|
| |||||
| Positive soft tissue surgicalmargins | 202 | 2.82 (1.57 to 5.06) | <.001 | 2.42 (1.21 to 4.87) | .013 |
|
| |||||
| Lymph node involvement | 202 | 2.48 (1.66 to 3.71) | <.001 | 2.34 (1.48 to 3.71) | <.001 |
NOTE. Bold values are statistically significant.
Abbreviations: HR, hazard ratio; OS, overall survival; RFS, recurrence-free survival.